International Journal of Radiation Oncology * Biology * Physics
Volume 73, Issue 5 , Pages 1343-1351 , 1 April 2009

Malignant Tumors of the Nasal Cavity and Paranasal Sinuses: Long-Term Outcome and Morbidity With Emphasis on Hypothalamic-Pituitary Deficiency

  • An Snyers, M.D.

      Affiliations

    • Department of Radiation Oncology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands
    • Corresponding Author InformationReprint requests to: An Snyers, M.D., Department of Radiation Oncology, Radboud University Nijmegen Medical Centre, Postbox 9101, 6500 HB Nijmegen, The Netherlands. Tel: (+31) 24-361-4515; Fax: (+31) 24-361-0792
    • ,
  • Geert O.R.J. Janssens, M.D.

      Affiliations

    • Department of Radiation Oncology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands
    • ,
  • Marcel B. Twickler, M.D., Ph.D.

      Affiliations

    • Department of Endocrinology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands
    • ,
  • Ad R. Hermus, M.D., Ph.D.

      Affiliations

    • Department of Endocrinology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands
    • ,
  • Robert P. Takes, M.D., Ph.D.

      Affiliations

    • Department of Otorhinolaryngology-Head and Neck Surgery, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands
    • ,
  • Arnoud C. Kappelle, M.D., Ph.D.

      Affiliations

    • Department of Neurology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands
    • ,
  • Matthias A.W. Merkx, M.D., Ph.D.

      Affiliations

    • Department of Oral and Maxillofacial Surgery, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands
    • ,
  • Piet Dirix, M.D.

      Affiliations

    • Department of Radiation Oncology, Leuvens Kanker Instituut, University Hospital Gasthuisberg, Leuven, Belgium
    • ,
  • Johannes H.A.M. Kaanders, M.D., Ph.D.

      Affiliations

    • Department of Radiation Oncology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands

Received 9 April 2008 ,Revised 28 May 2008 ,Accepted 19 July 2008.

References 

  1. Parsons JT, Mendenhall WM, Stringer SP, et al. Nasal cavity and paranasal sinuses. In:  Perez CA,  Brady LW editor. Principles and practice of radiation oncology. 3rd ed.. Philadelphia: Lippincott-Raven; 1997;p. 941–959
  2. Grau C, Jakobsen MH, Harbo G, et al. Sino-nasal cancer in Denmark 1982-1991—A nationwide survey. Acta Oncol. 2001;40:19–23
  3. Jansen EP, Keus RB, Hilgers FJ, et al. Does the combination of radiotherapy and debulking surgery favor survival in paranasal sinus carcinoma?. Int J Radiat Oncol Biol Phys. 2000;48:27–35
  4. Dulguerov P, Jacobsen MS, Allal AS, et al. Nasal and paranasal sinus carcinoma: Are we making progress? A series of 220 patients and a systematic review. Cancer. 2001;92:3012–3029
  5. Hoppe BS, Stegman LD, Zelefsky MJ, et al. Treatment of nasal cavity and paranasal sinus cancer with modern radiotherapy techniques in the postoperative setting—The MSKCC experience. Int J Radiat Oncol Biol Phys. 2007;67:691–702
  6. Dirix P, Nuyts S, Geussens Y, et al. Malignancies of the nasal cavity and paranasal sinuses: Long-term outcome with conventional or 3D-conformal radiotherapy. Int J Radiat Oncol Biol Phys. 2007;69:1042–1050
  7. In:  Sobin LH,  Wittekind Ch editor. TNM classification of malignant tumours. 6th ed.. New York: Wiley; 2002;p. 43–47
  8. Rubin P, Constine LS, Fajardo LF, et al. Overview: Late effects of normal tissues (LENT) scoring system. Int J Radiat Oncol Biol Phys. 1995;31:1041–1042
  9. Jiang GL, Ang KK, Peters LJ, et al. Maxillary sinus carcinomas: Natural history and results of postoperative radiotherapy. Radiother Oncol. 1991;21:193–200
  10. Tiwari R, Hardillo JA, Tobi H, et al. Carcinoma of the ethmoid: Results of treatment with conventional surgery and post-operative radiotherapy. Eur J Surg Oncol. 1999;25:401–405
  11. Claus F, Boterberg T, Ost P, et al. Postoperative radiotherapy for adenocarcinoma of the ethmoid sinuses: Treatment results for 47 patients. Int J Radiat Oncol Biol Phys. 2002;54:1089–1094
  12. Duthoy W, Boterberg T, Claus F, et al. Postoperative intensity-modulated radiotherapy in sinonasal carcinoma: Clinical results in 39 patients. Cancer. 2005;104:71–82
  13. Dirix P, Nuyts S, Vanstraelen B, et al. Post-operative intensity-modulated radiotherapy for malignancies of the nasal cavity and paranasal sinuses. Radiother Oncol. 2007;85:385–391
  14. Bristol IJ, Ahamad A, Garden AS, et al. Postoperative radiotherapy for maxillary sinus cancer: Long-term outcomes and toxicities of treatment. Int J Radiat Oncol Biol Phys. 2007;68:719–730
  15. Lee MM, Vokes EE, Rosen A, et al. Multimodality therapy in advanced paranasal sinus carcinoma: Superior long-term results. Cancer J Sci Am. 1999;5:219–223
  16. Samant S, Robbins KT, Vang M, et al. Intra-arterial cisplatin and concomitant radiation therapy followed by surgery for advanced paranasal sinus cancer. Arch Otolaryngol Head Neck Surg. 2004;130:948–955
  17. Lomax AJ, Goitein M, Adams J. Intensity modulation in radiotherapy: Photon versus protons in the paranasal sinus. Radiother Oncol. 2003;66:11–18
  18. Waldron JN, O'Sullivan B, Gullane P, et al. Carcinoma of the maxillary antrum: A retrospective analysis of 110 cases. Radiother Oncol. 2000;57:167–173
  19. Le QT, Fu KK, Kaplan MJ, et al. Lymph node metastasis in maxillary sinus carcinoma. Int J Radiat Oncol Biol Phys. 2000;46:541–549
  20. Paulino AC, Fisher SG, Marks JE. Is prophylactic neck irradiation indicated in patients with squamous cell carcinoma of the maxillary sinus?. Int J Radiat Oncol Biol Phys. 1997;39:283–289
  21. Jeremic B, Nguyen-Tan PF, Bamberg M. Elective neck irradiation in locally advanced squamous cell carcinoma of the maxillary sinus: A review. J Cancer Res Clin Oncol. 2002;128:235–238
  22. Krengli M, Masini L, Kaanders JH, et al. Radiotherapy in the treatment of mucosal melanoma of the upper aerodigestive tract: Analysis of 74 cases. A rare cancer network study. Int J Radiat Oncol Biol Phys. 2006;65:751–759
  23. Darzy KH, Shalet SM. Pathophysiology of radiation-induced growth hormone deficiency: Efficacy and safety of GH replacement. Growth Horm IGF Res. 2006;16(Suppl. A):S30–S40
  24. Littley MD, Shalet SM, Beardwell CG, et al. Radiation-induced hypopituitarism is dose-dependent. Clin Endocrinol. 1989;31:363–373
  25. Lam KS, Tse VK, Wang C, et al. Effects of cranial irradiation on hypothalamic-pituitary function—A 5-year longitudinal study in patients with nasopharyngeal carcinoma. QJM. 1991;78:165–176
  26. Littley MD, Shalet SM, Beardwell CG, et al. Hypopituitarism following external radiotherapy for pituitary tumors in adults. QJM. 1989;70:145–160
  27. Samaan NA, Vieto R, Schulz PN, et al. Hypothalamic, pituitary and thyroid dysfunction after radiotherapy to the head and neck. Int J Radiat Oncol Biol Phys. 1982;8:1857–1867
  28. Lam KS, Ho JH, Lee AW, et al. Symptomatic hypothalamic-pituitary dysfunction in nasopharyngeal carcinoma patients following radiation therapy: A retrospective study. Int J Radiat Oncol Biol Phys. 1987;13:1343–1350
  29. Sham J, Choy D, Kwong PW, et al. Radiotherapy for nasopharyngeal carcinoma: Shielding the pituitary may improve therapeutic ratio. Int J Radiat Oncol Biol Phys. 1994;29:699–704
  30. Darzy KH, Shalet SM. Hypopituitarism as a consequence of brain tumors and radiotherapy. Pituitary. 2005;8:203–211

 The current address for M.B.T. is Department of Vascular Medicine, Academic Medical Center/University of Amsterdam, Amsterdam, The Netherlands.

 Conflict of interest: none.

PII: S0360-3016(08)03180-5

doi: 10.1016/j.ijrobp.2008.07.040

International Journal of Radiation Oncology * Biology * Physics
Volume 73, Issue 5 , Pages 1343-1351 , 1 April 2009

Article Tools

* Image Usage & Resolution